Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Aug;39(8):1815–1819. doi: 10.1128/aac.39.8.1815

Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.

C M Brandt 1, M S Rouse 1, B M Tallan 1, N W Laue 1, W R Wilson 1, J M Steckelberg 1
PMCID: PMC162831  PMID: 7486924

Abstract

The efficacy of cefazolin or cefpirome alone or combined with rifampin was compared with that of vancomycin alone or combined with rifampin in an experimental model of methicillin-resistant, beta-lactamase-producing, coagulase-negative staphylococcal endocarditis. Phenotypically, the mecA gene-positive strain used in vivo did not exhibit methicillin resistance by the agar dilution or disk susceptibility method but was resistant in vitro (oxacillin MIC, 64 micrograms/ml) by the microtiter dilution method with 2% NaCl supplementation. Macrodilution broth susceptibilities of standard inocula failed to demonstrate cross-resistance of staphylococci to cefazolin (MIC, 8 micrograms/ml) or cefpirome (MIC, 4 micrograms/ml). In vivo, vancomycin and cefpirome had similar activities, and both regimens were more effective than was cefazolin alone. While the MIC of rifampin was low (0.031 micrograms/ml), monotherapy with rifampin resulted in a bimodal distribution of outcomes due to the expected emergence of resistant mutants. The results in vitro of time-kill synergy studies using rifampin in combination with cefazolin or cefpirome varied with the antimicrobial concentrations tested and did not reliably predict activities in vivo of rifampin-beta-lactam combination therapies. Cefpirome, but not cefazolin or vancomycin, in combination with rifampin was synergistic in vivo. Cefpirome in combination with rifampin was more effective than was cefazolin in combination with rifampin. Both cephalosporin-rifampin regimens were significantly more effective than was cephalosporin or vancomycin monotherapy and were as effective as vancomycin combined with rifampin. These data support further evaluation of rifampin-beta-lactam combinations as possible alternative therapies to vancomycin-containing regimens for selected methicillin-resistant coagulase-negative staphylococcal infections.

Full Text

The Full Text of this article is available as a PDF (249.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L., Pennell E. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob Agents Chemother. 1990 Sep;34(9):1720–1724. doi: 10.1128/aac.34.9.1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aubert G., Passot S., Lucht F., Dorche G. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection. J Antimicrob Chemother. 1990 Mar;25(3):491–493. doi: 10.1093/jac/25.3.491. [DOI] [PubMed] [Google Scholar]
  3. Bartoloni A., Colao M. G., Orsi A., Dei R., Giganti E., Parenti F. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile. J Antimicrob Chemother. 1990 Nov;26(5):627–633. doi: 10.1093/jac/26.5.627. [DOI] [PubMed] [Google Scholar]
  4. Berry A. J., Johnston J. L., Archer G. L. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1986 May;29(5):748–752. doi: 10.1128/aac.29.5.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bisno A. L., Dismukes W. E., Durack D. T., Kaplan E. L., Karchmer A. W., Kaye D., Rahimtoola S. H., Sande M. A., Sanford J. P., Watanakunakorn C. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA. 1989 Mar 10;261(10):1471–1477. [PubMed] [Google Scholar]
  6. Brandt C. M., Rouse M. S., Tallan B. M., Wilson W. R., Steckelberg J. M. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus. Antimicrob Agents Chemother. 1994 Sep;38(9):2191–2193. doi: 10.1128/aac.38.9.2191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chambers H. F., Sachdeva M. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J Infect Dis. 1990 Jun;161(6):1170–1176. doi: 10.1093/infdis/161.6.1170. [DOI] [PubMed] [Google Scholar]
  8. Eng R. H., Smith S. M., Buccini F. J., Cherubin C. E. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. J Antimicrob Chemother. 1985 Feb;15(2):201–207. doi: 10.1093/jac/15.2.201. [DOI] [PubMed] [Google Scholar]
  9. Froggatt J. W., Johnston J. L., Galetto D. W., Archer G. L. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother. 1989 Apr;33(4):460–466. doi: 10.1128/aac.33.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galetto D. W., Boscia J. A., Kobasa W. D., Kaye D. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. J Infect Dis. 1986 Jul;154(1):69–75. doi: 10.1093/infdis/154.1.69. [DOI] [PubMed] [Google Scholar]
  11. Garrison P. K., Freedman L. R. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med. 1970 Jun;42(6):394–410. [PMC free article] [PubMed] [Google Scholar]
  12. Geha D. J., Uhl J. R., Gustaferro C. A., Persing D. H. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol. 1994 Jul;32(7):1768–1772. doi: 10.1128/jcm.32.7.1768-1772.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldman P. L., Petersdorf R. G. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis. 1980 Mar;141(3):331–337. doi: 10.1093/infdis/141.3.331. [DOI] [PubMed] [Google Scholar]
  14. Goldstein F. W., Coutrot A., Sieffer A., Acar J. F. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1990 May;34(5):899–900. doi: 10.1128/aac.34.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hackbarth C. J., Chambers H. F. Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob Agents Chemother. 1989 Jul;33(7):995–999. doi: 10.1128/aac.33.7.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hackbarth C. J., Chambers H. F. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother. 1989 Jul;33(7):991–994. doi: 10.1128/aac.33.7.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hedin G., Hambraeus A. Screening tests for the detection of methicillin resistance in Staphylococcus epidermidis. J Antimicrob Chemother. 1991 Nov;28(5):681–694. doi: 10.1093/jac/28.5.681. [DOI] [PubMed] [Google Scholar]
  18. Hedin G., Löfdahl S. Detecting methicillin-resistant Staphylococcus epidermidis--disc diffusion, broth breakpoint or polymerase chain reaction? APMIS. 1993 Apr;101(4):311–318. doi: 10.1111/j.1699-0463.1993.tb00116.x. [DOI] [PubMed] [Google Scholar]
  19. Hinman A. R., Kirby C. D., Eddins D. L., Orenstein W. A., Bernier R. H., Turner P. M., Bart K. J. Elimination of indigenous measles from the United States. Rev Infect Dis. 1983 May-Jun;5(3):538–545. doi: 10.1093/clinids/5.3.538. [DOI] [PubMed] [Google Scholar]
  20. Huang M. B., Gay T. E., Baker C. N., Banerjee S. N., Tenover F. C. Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods. J Clin Microbiol. 1993 Oct;31(10):2683–2688. doi: 10.1128/jcm.31.10.2683-2688.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Karchmer A. W., Archer G. L., Dismukes W. E. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983 Apr;98(4):447–455. doi: 10.7326/0003-4819-98-4-447. [DOI] [PubMed] [Google Scholar]
  22. Kobayashi Y., Kizaki M., Kawakami Y., Uchida H., Ikeda Y. Assessment of oxacillin salt agar for detection of MRSA identified by presence of the mecA gene. J Hosp Infect. 1993 Apr;23(4):279–285. doi: 10.1016/0195-6701(93)90145-p. [DOI] [PubMed] [Google Scholar]
  23. Lowy F. D., Wexler M. A., Steigbigel N. H. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis. J Lab Clin Med. 1982 Jul;100(1):94–104. [PubMed] [Google Scholar]
  24. McCabe W. R., Lorian V. Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci. 1968 Oct;256(4):255–265. doi: 10.1097/00000441-196810000-00007. [DOI] [PubMed] [Google Scholar]
  25. Neu H. C. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams. Curr Clin Top Infect Dis. 1987;8:37–61. [PubMed] [Google Scholar]
  26. O'Brien P. C., Shampo M. A. Statistical considerations for performing multiple tests in a single experiment. 2. Comparisons among several therapies. Mayo Clin Proc. 1988 Aug;63(8):816–820. doi: 10.1016/s0025-6196(12)62363-5. [DOI] [PubMed] [Google Scholar]
  27. Pierre J., Williamson R., Bornet M., Gutmann L. Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole. Antimicrob Agents Chemother. 1990 Sep;34(9):1691–1694. doi: 10.1128/aac.34.9.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rouse M. S., Wilcox R. M., Henry N. K., Steckelberg J. M., Wilson W. R. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother. 1990 Feb;34(2):273–276. doi: 10.1128/aac.34.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sabath L. D., Barrett F. F., Wilcox C., Gerstein D. A., Finland M. Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (Bethesda) 1968;8:302–306. [PubMed] [Google Scholar]
  30. Sande M. A., Johnson M. L. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis. 1975 Apr;131(4):367–375. doi: 10.1093/infdis/131.4.367. [DOI] [PubMed] [Google Scholar]
  31. Sanyal D., Williams A. J., Johnson A. P., George R. C. The emergence of vancomycin resistance in renal dialysis. J Hosp Infect. 1993 Jul;24(3):167–173. doi: 10.1016/0195-6701(93)90046-3. [DOI] [PubMed] [Google Scholar]
  32. Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987 Apr 9;316(15):927–931. doi: 10.1056/NEJM198704093161507. [DOI] [PubMed] [Google Scholar]
  33. Sorrell T. C., Collignon P. J. A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother. 1985 Aug;16(2):235–241. doi: 10.1093/jac/16.2.235. [DOI] [PubMed] [Google Scholar]
  34. Steckelberg J. M., Rouse M. S., Tallan B. M., Osmon D. R., Henry N. K., Wilson W. R. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob Agents Chemother. 1993 Mar;37(3):554–558. doi: 10.1128/aac.37.3.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Thornsberry C., McDougal L. K. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol. 1983 Nov;18(5):1084–1091. doi: 10.1128/jcm.18.5.1084-1091.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vazquez G. J., Archer G. L. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1980 Feb;17(2):280–285. doi: 10.1128/aac.17.2.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Veach L. A., Pfaller M. A., Barrett M., Koontz F. P., Wenzel R. P. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 1990 Sep;28(9):2064–2068. doi: 10.1128/jcm.28.9.2064-2068.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Woods G. L., Hall G. S., Rutherford I., Pratt K. J., Knapp C. C. Detection of methicillin-resistant Staphylococcus epidermidis. J Clin Microbiol. 1986 Sep;24(3):349–352. doi: 10.1128/jcm.24.3.349-352.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zinner S. H., Lagast H., Klastersky J. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis. 1981 Oct;144(4):365–371. doi: 10.1093/infdis/144.4.365. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES